This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kaer Biotherapeutics Corporation. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations by Jinghai Yi in Aerosol Drug Delivery
Introduction
Jinghai Yi is an accomplished inventor based in Des Plaines, IL (US). He has made significant contributions to the field of aerosol processing and inhalation methods, particularly in high dose rate aerosol drug delivery systems. His innovative approach aims to enhance the efficiency and effectiveness of drug delivery through inhalation.
Latest Patents
Jinghai Yi holds a patent for an "Aerosol processing and inhalation method and system for high dose rate aerosol drug delivery." This patent describes a method and system capable of delivering respirable solid aerosols derived from aqueous- or nonaqueous-based solutions containing therapeutic agents. The system integrates an aerosol generator, an aerosol evaporator, an aerosol concentrator, and an aerosol flow regulator. The generator produces droplets sized between 10-30 µm with a narrow size distribution. The aerosol jet is arrested by a coaxial counter-flow heated air jet and evaporated rapidly by annular swirling heated air. The process effectively removes unwanted solvent vapor from the aerosol stream, allowing the output aerosol to carry dry particles for inhalation by patients. The respiratory-governed control of the aerosol fluid generation system ensures that the fluid containing the test agent is delivered throughout inhalation.
Career Highlights
Jinghai Yi is currently associated with Kaer Biotherapeutics Corporation, where he continues to develop innovative solutions in aerosol drug delivery. His work is pivotal in advancing therapeutic methods that can significantly improve patient outcomes.
Collaborations
Jinghai Yi collaborates with notable colleagues, including Donovan B Yeates and Guanglin Li, who contribute to the research and development efforts at Kaer Biotherapeutics Corporation.
Conclusion
Jinghai Yi's contributions to aerosol drug delivery represent a significant advancement in medical technology. His innovative methods and systems are poised to enhance the efficacy of therapeutic treatments through inhalation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile